RXRX (Recursion Pharma) Stock Quotes

This daily price chart for Recursion Pharmaceuticals (RXRX) reflects the quotes of a company that has deployed autonomous robots for large-scale biological testing. The business generates revenue through contracts with pharmaceutical behemoths, utilizing neural networks to optimize drug formulas. The current metric stands at 3.58, while growth prospects rely on the success of clinical trials, support from NVIDIA, and the volume of free cash flow.

Price Performance Chart: Recursion Pharmaceuticals (RXRX) for 07/04/2022 - 11/11/2026

Analytical breakdowns for Recursion Pharmaceuticals

- stock value and consensus price forecast:

Price Chart Recursion Pharmaceuticals|RXRX - Fair Value Consensus

- business market valuation indicators:

Market Valuation Recursion Pharmaceuticals Inc|RXRX - Business Value

- issuer book value statistics:

Net Assets per Single Share Recursion|RXRX - Accounting Value of Company|Market Cap to Net Assets Ratio recursion.com|RXRX - Total Business Assets

- business debt structure and liquidity details:

Total Debt to Capital Recursion Pharmaceuticals|RXRX - Long-Term Debt to Capital|Short-Term Debt to Capital Recursion Pharmaceuticals, Inc.|RXRX - Company Total Debt Obligations|Debt to Book Capitalization Ratio Recursion Pharmaceuticals Inc|RXRX - Company Long-Term Loans and Borrowings|Company Short-Term Debts Recursion|Quick Ratio recursion.com

- company profitability and valuation multiples indicators:

RXRX - Net Income|Future Profit Recursion Pharmaceuticals|RXRX - P/E Multiple|Future Price to Earnings Recursion Corp|RXRX - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Recursion Pharmaceuticals Inc|RXRX - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Recursion|RXRX - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months recursion.com|RXRX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Recursion Pharmaceuticals

Basic company analysis:RXRX Recursion Pharma

The price reflects the market value of a single unit of the company's equity. This price action captures the real-time balance of asset supply and demand. The metric measures current capitalization through the lens of investor expectations regarding future cash flows. For Recursion Pharmaceuticals (RXRX), quotes serve as an indicator of confidence in the effectiveness of AI algorithms. Volatility here depends directly on drug development success and the quality of genetic data.

Direct competitors